SI1581219T1 - Zdravljenje odvisnosti od psihostimulansov - Google Patents

Zdravljenje odvisnosti od psihostimulansov

Info

Publication number
SI1581219T1
SI1581219T1 SI200331548T SI200331548T SI1581219T1 SI 1581219 T1 SI1581219 T1 SI 1581219T1 SI 200331548 T SI200331548 T SI 200331548T SI 200331548 T SI200331548 T SI 200331548T SI 1581219 T1 SI1581219 T1 SI 1581219T1
Authority
SI
Slovenia
Prior art keywords
treatment
cocaine
addiction
symptoms
relates
Prior art date
Application number
SI200331548T
Other languages
English (en)
Inventor
Igor Krisch
Marko Zivin
Natasa Milivojevic
Rudolf Rucman
Breda Bole
Uros Urleb
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of SI1581219T1 publication Critical patent/SI1581219T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200331548T 2002-12-17 2003-12-11 Zdravljenje odvisnosti od psihostimulansov SI1581219T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200200305A SI21351A (sl) 2002-12-17 2002-12-17 Zdravljenje odvisnosti od psihostimulansov
PCT/SI2003/000045 WO2004054578A1 (en) 2002-12-17 2003-12-11 Treatment of psychostimulant addiction
EP03781272A EP1581219B1 (en) 2002-12-17 2003-12-11 Treatment of psychostimulant addiction

Publications (1)

Publication Number Publication Date
SI1581219T1 true SI1581219T1 (sl) 2009-06-30

Family

ID=32590099

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200200305A SI21351A (sl) 2002-12-17 2002-12-17 Zdravljenje odvisnosti od psihostimulansov
SI200331548T SI1581219T1 (sl) 2002-12-17 2003-12-11 Zdravljenje odvisnosti od psihostimulansov

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200200305A SI21351A (sl) 2002-12-17 2002-12-17 Zdravljenje odvisnosti od psihostimulansov

Country Status (7)

Country Link
US (1) US7632843B2 (sl)
EP (1) EP1581219B1 (sl)
AT (1) ATE418985T1 (sl)
AU (1) AU2003288888A1 (sl)
DE (1) DE60325642D1 (sl)
SI (2) SI21351A (sl)
WO (1) WO2004054578A1 (sl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935429A (en) 1985-10-25 1990-06-19 Dackis Charles A Method of treating psychostimulant addiction
US5480885A (en) * 1991-07-01 1996-01-02 Lek, Tovarna Farmacevtskih In Kemicnih Ergoline derivatives of 1-propinylamine, a process for the manufacture thereof and the use thereof for medicaments
US5441961A (en) 1992-08-27 1995-08-15 Eli Lilly And Company Substituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolines
TW252979B (sl) 1992-12-24 1995-08-01 Erba Carlo Spa
WO2001041763A1 (en) 1999-12-10 2001-06-14 University Of Cincinnati Treatment of addiction disorders

Also Published As

Publication number Publication date
ATE418985T1 (de) 2009-01-15
US7632843B2 (en) 2009-12-15
US20060014775A1 (en) 2006-01-19
EP1581219B1 (en) 2008-12-31
SI21351A (sl) 2004-06-30
EP1581219A1 (en) 2005-10-05
DE60325642D1 (de) 2009-02-12
WO2004054578A1 (en) 2004-07-01
AU2003288888A1 (en) 2004-07-09

Similar Documents

Publication Publication Date Title
AU755119B2 (en) Serotonergic 5HT2 agonists for treating glaucoma
AU2006271870B2 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
DE60225673T2 (de) Kappa-opioid-rezeptor-liganden
RU98101470A (ru) Новая стабильная лекарственная композиция для получения аэрозолей содержания рабочего газа
EP0498466A1 (en) Indazole-3-carboxamide and -3-carboxylic acid derivatives
MY127807A (en) Tartrate salts of 5,8,14-triazateracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
MY125414A (en) Aminopropylphosphinic acids
ATE311765T1 (de) Mischung enthaltend procyanidine zur verminderung des appetits bei säugetieren
MXPA04003192A (es) Sales de acido succinico de 5, 7, 14-triazatetraciclo ?10.3.1.02,11.04,9? -hexadeca-2(11), 3, 5, 7, 9-pentaeno y composiciones farmacetucias de las mismas.
EP0911331A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
CA2450359A1 (en) Dosage regimen and pharmaceutical composition for emergency contraception
MXPA03007885A (es) Norbuprenorfina n-but-3-enilo y metodos de uso.
MY153713A (en) A pharmaceutical composition comprising 3, 4-dihydro-3-methyl-4-oxoimidazo [5,1-d]-1,2,3,5-tetrazine-8-carboxylate
SE9904507D0 (sv) New compounds
MXPA04000779A (es) 7-aza[2.2.1]bicicloheptanos sustituidos con arilo para el tratamiento de enfermedades.
WO2003045326A3 (en) Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
WO1996001634B1 (en) Long-acting oxytetracycline composition
SI1581219T1 (sl) Zdravljenje odvisnosti od psihostimulansov
NZ218175A (en) Prazosin-pirbuterol combination for bronchodilation
EP0323146A3 (en) Dopamine-beta-hydroxylase inhibitors
EP0246888A3 (en) Dopamine-beta-hydroxylase inhibitors
CA2452920A1 (en) Benzo [g] quinoline derivatives for treating glaucoma and myopia
WO2004084801A3 (en) Treatments for leishmaniasis
ES489042A1 (es) Procedimiento de preparar benciloxi-4 piperidina y sus salesfarmaceuticamente aceptables
GR3033649T3 (en) Growth factor compositions, preparation and use.